Page 3

BeLab1407 brings $20m to UK universities
Evotec has partnered Bristol-Myers Squibb to launch another Bridge programme, this time focusing on the universities of Birmingham, Dundee, Edinburgh and Nottingham.
Daily Deal Round Up: May 6, 2021
Opioid addiction care provider Groups Recover Together and healthcare management platform developer Vim each raised $60m, with Optum Ventures backing both rounds.
Subsector: healthcare IT and administration
A decade or more after setting up the golden age of corporate venturing units were set up with a focus on life sciences and healthcare, such as US-listed conglomerate Alphabet’s GV (formerly known as Google Ventures) and US-listed drugs company Merck’s Global Health Innovation Fund (GHIF), and the returns have surpassed many expectations.
Corporates help feed Vida Health with $110m
Workday Ventures has returned to back the telehealth platform developer’s series D round, which included Axa Venture Partners, Centene and GuideWell.
R1 RCM buys VisitPay for $300m
Intermountain Healthcare, Inova Health System, Ascension Ventures and St Luke’s Health System are all set to exit the medical payment software producer.
Daily Deal Round Up: May 5, 2021
SoftBank Vision Fund led a $75m round valuing OKR platform developer WorkBoard at $800m while therapist network provider Headway hit a $750m valuation.
Collective Health clinches $280m
The health benefits software provider pushed its valuation to $1.5bn in a series F round led by Health Care Service Corporation and backed by Sun Life and SoftBank.
Affinia achieves $110m series B close
GV, Mass General Brigham Ventures and existing investor Lonza helped Affinia Therapeutics raise $110m that will fund the progress of its gene therapy candidates.
Inivata inspires $390m acquisition
NeoGenomics has agreed to buy portfolio company Inivata, a liquid biopsy platform developer, a year after it invested $25m.
Daily Deal Round Up: May 4, 2021
Solidia Technologies, Kelun Biotech and Doer Biologics all raised more than $70m while Sony added cash to a round valuing Discord at $7bn.

test reg